PARP1 and Parkinson disease: To investigate whether PARP1 over‐activation is involved in autophagy dysfunction in PD, we treated α‐synucleinA53T SN4741 cells with PARP1‐specific inhibitor Veliparib (10 μM, 12 hr) or siPARP1.